Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant mesenchymal tumor × cixutumumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Sarcoma 5 Rhabdomyosarcoma 4 Neoplasms 4 Osteosarcoma 3 Breast Neoplasms 3 Sarcoma, Synovial 2 Sarcoma, Ewing 2 Prostatic Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Adrenocortical Carcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Retinoblastoma 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neuroectodermal Tumors 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Liposarcoma 1 Leiomyosarcoma 1 Insulin-Like Growth Factor I, Resistance To 1 Hepatoblastoma 1 Hemangiosarcoma 1

Interventions

Radiotherapy, Conformal 2 Ifosfamide 2 Doxorubicin 2 romidepsin 1 indolepropanol phosphate 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 HhAntag691 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Filgrastim 1 Etoposide 1 Dactinomycin 1 Cyclophosphamide 1 Blotting, Western 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡